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Urinary iodine concentrations of pregnant women in rural
Bangladesh: A longitudinal study
Filip Rydbeck1, Matteo Bottai2, Fahmida Tofail3, Lars-Åke Persson4 and Maria Kippler1
Iodine is an essential dietary element required for normal fetal growth and development. We aimed to explore intraindividual and
interindividual variations in iodine intake in pregnant women and whether non-dietary factors might inﬂuence the intake. Iodine
intake was assessed in 271 women, residing in Matlab, rural Bangladesh, by measuring their urinary iodine concentration (UIC) at
gestational week (GW) 8, 14, 19, and 30 with inductively coupled plasma mass spectrometry. The women’s UIC increased
signiﬁcantly during pregnancy (median 241 (GW8) and 300mg/l (GW30)). About 6% of the women had insufﬁcient iodine intake
(UICo150mg/l) and 10% had excessive iodine intake (UICZ500mg/l) at all of their four sampling occasions. The women’s UIC were
dependent on their education, socio-economic status, and BMI, as well as the season of sampling and iodine concentrations in
drinking water. Supplementation with a multi-micronutrient capsule, including 150 mg potassium iodine, increased the UIC in
women with the lowest UIC (10th percentile) at GW30 but decreased the UIC in women with the highest UIC (90th percentile) at
GW30. In conclusion, median UIC throughout pregnancy indicated adequate intake of iodine among pregnant women in Matlab,
but, notably, consistently insufﬁcient and excessive intake was also prevalent.
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INTRODUCTION
Iodine is an essential component of thyroid hormones, which in
turn, are required for normal growth and development.1 The
global iodine status has improved markedly during the past
decade,2,3 but still it has been estimated that 1.88 billion people of
the global population have insufﬁcient iodine intake.2 The diet is
considered as the main source of iodine. A large part of the
absorbed dietary iodine is eventually excreted in urine, primarily
as iodide, and therefore the urinary iodine concentration (UIC) is
considered a valid biomarker of recent iodine intake.1,4 In fact, the
World Health Organization (WHO) has recommended that the
median UIC is to be used as a key indicator of a population’s
iodine status.1 Currently, the median UIC is mainly monitored in
school-aged children (6–12 years of age) as they are easy to assess
via school-based surveys, and the optimal UIC for them is
considered to range between 100 mg/l and 199mg/l.
Pregnancy is associated with an increased iodine requirement;
mainly because of (1) increased thyroxin (T4) synthesis to maintain
an euthyroidal state and to enable transfer of thyroid hormone to
the fetus, primarily during the ﬁrst trimester; before functioning of
the fetal thyroid gland; (2) iodine transfer to the fetus’ own thyroid
gland during later gestation; and (3) increased renal clearance,
resulting in loss of iodine in urine.5 Therefore, to ensure adequate
iodine status during pregnancy, a higher reference range for the
median UIC has been established for pregnant women (150 mg/l
to 249 mg/l).6 Iodine deﬁciency during pregnancy has been
associated with increased risk of spontaneous abortion, stillbirth,
perinatal mortality, and foremost impaired neurodevelopment in
the offspring.7,8 Thus, pregnant women are considered as a high-
risk population group. Despite this, only a limited number of
countries have completed national or large sub-national surveys
of UIC in pregnant women.2
The latest national survey in Bangladesh, conducted in 2004–
2005, reported a median UIC of 158 mg/l among pregnant women.9
Recently, a study on pregnant women in rural northwestern
Bangladesh reported even lower median UIC of 66mg/l and 55mg/l
in early and late pregnancy, respectively.10 This clearly emphasizes
the need for continuous national monitoring of iodine intake
among pregnant women. The aim of the present study was to
explore intraindividual and interindividual differences in iodine
intake of pregnant women, residing in Matlab, a rural area about
50 km southeast of Dhaka in Bangladesh and to assess non-dietary
factors that may inﬂuence the women’s iodine intake (e.g.
demographic characteristics, season, iodine supplementation, and
iodine in drinking water).
MATERIALS AND METHODS
Study Area, Design and Participants
The present study of iodine status during pregnancy is part of our ongoing
studies concerning the impact of various environmental factors on early
life development,11 which, in turn, are nested into a randomized
population-based food and micronutrient supplementation trial
(Maternal and Infant Nutrition Interventions, Matlab; MINIMat) during
pregnancy. The MINIMat trial was conducted in Matlab, a rural sub-district
located about 50 km southeast of Dhaka, Bangladesh.12,13 In Matlab, there
is a well-established health and demographic surveillance system (HDSS)
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with community health research workers who perform monthly visits to
every household. This enabled an early detection of pregnancy, on average
at gestational week (GW) 8.
All women in the MINIMat trial were randomized to both food and
micronutrient supplementation during pregnancy; two food groups and
three micronutrient supplementation groups, resulting in a total of six
different supplementation groups.12 The food supplementation (608 kcal
of energy and 18 g of vegetable protein) was provided 6 days per week
throughout pregnancy and the two different groups were deﬁned as either
early invitation (in connection with detection of pregnancy, around GW9)
or usual care invitation (around GW20). The micronutrient supple-
mentation was initiated at GW14 and taken daily throughout pregnancy
and the three different groups consisted of 60mg iron and 400mg
folic acid (Fe60Fol; usual care), 30mg iron and 400mg folic acid (Fe30Fol),
or a multiple micronutrient supplementation capsule containing 15
micronutrients (MMS), including 150mg iodine (potassium iodine).14
In total, the MINIMat trial recruited 4436 pregnant women from
November 2001 through October 2003.12 During one calendar year, from
January through December 2002, 2119 women were recruited to the
MINIMat trial. From these 2119 women, we randomly selected 500 women
for assessing their UIC at GW8, GW14, GW19, and GW30, and whether the
UIC were associated with the women’s demographic characteristics. In
total, 392 out of the 500 randomly selected women were followed until
delivery, and out of them 271 women provided enough urine to enable
measurements of UIC at all four sampling occasions (Figure 1). To assess
whether the food and micronutrient supplementation ingested during
pregnancy had inﬂuenced the women’s UIC, we used the urinary
concentrations measured at GW14 (baseline of the micronutrient
supplementation) and GW30, which resulted in a ﬁnal sample of 307
women (Figure 1). Finally, to explore whether drinking water contributed
to the women’s UIC, we measured iodine in 100 water samples collected
from tube-wells used during pregnancy throughout Matlab.
The study was approved by the ethics committee both at the
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
and at Karolinska Institutet, Sweden. Consent was obtained from all women,
and they were free to refrain from any part of the study at any time.
Sample Collection and Measurements of Iodine
We measured UIC, considered to be a valid biomarker for assessment of
iodine intake on population basis.1 Urine was collected as spot samples,
and the collection procedure has been described in detail elsewhere.15 In
short, urine collection at GW8 was performed at home, whereas the
collection of urine at GW14, 19, and 30 was performed during the
antenatal visits at the health-care facilities. Urine was collected in plastic
urine collection cups, transferred to 24-ml plastic bottles, and thereafter
frozen at  70 1C. Collection of water samples was performed in a parallel
study assessing the concentration of arsenic in all functioning tube-wells in
the Matlab area in 2002–2003.16 Water was sampled in acidiﬁed 24-ml
plastic bottles after approximately 30 strokes on the pump, minimizing
contamination from the pump, and then frozen at  20 1C.
Concentrations of iodine in urine and water were measured with
inductively coupled plasma mass spectrometry (ICP-MS; Agilent 7700x;
Agilent Technologies, Tokyo, Japan) equipped with an octopole reaction
system. The ICP-MS was operated in standard mode (no gas) and iodine127
was monitored with iridium193 as internal standard. The concentration of
the internal standard was 200mg/l, and it was added on-line at a ﬂow rate
of 0.04ml/min. Carrier gas ﬂow was 0.80 l/min and dilution gas ﬂow 0.30 l/
min. The sample uptake ﬂow rate was 0.4ml/min. Standard solutions of
iodine and iridium were prepared daily in 0.1% ammonium hydroxide
solution (NH4OH; 25% suprapur, Merck, Darmstadt, Germany) from
1000mg/l stock solutions (CPI international, Amsterdam, The Netherlands,
and Inorganic Venture, VA, USA, respectively). The concentrations
of the external calibration standards ranged from 0.1 mg/l to 200mg/l.
Samples were initially diluted 1:10 with 0.1% NH4OH, and if needed, the
dilution was thereafter increased. The limit of detection (LOD),
calculated by multiplying the SD of the blanks with three, was o0.5mg/l,
and no samples contained an iodine concentration oLOD. Commercial
control materials were included in each analytical run as quality
control (Seronorm Trace Elements Urine Blank, REF 201305, LOT
OK4636 and Seronorm Trace Elements Urine, REF 201205, LOT NO2525;
SERO AS, Billingstad, Norway), and the obtained concentrations
(mean±SD) of iodine were 130±10mg/l (n¼ 142; recommended value
139±8mg/l) and 281±23mg/l (n¼ 174; recommended value 282±18mg/l),
respectively.
All spot urine sample concentrations were adjusted for the speciﬁc
gravity (SG) in order to compensate for the variation in dilution (UIC
(mean SG 1/individual SG 1)).17 The SG was measured with a digital
refractometer (EUROMEX RD712 Clinical Refractometer, Holland). The
overall mean SG throughout pregnancy (GW8, GW14, GW19, and GW30)
was 1.010 g/ml.
Demographic Factors
Data on maternal and family characteristics (age, weight in early
pregnancy (on average GW8), height, parity, education, socio-economic
status, and use of tobacco/betel) were obtained within the MINIMat trial as
well as from the HDSS database maintained by icddr,b. Socio-economic
status was estimated through a wealth index, based mainly on several
household assets.18 Tobacco smoking and betel/tobacco-chewing habits
during pregnancy were categorized as never or ever. The season of urine
sampling was categorized into premonsoon (January–May), monsoon
(June–September), and postmonsoon (October–December).
Statistical Analyses
The statistical analyses were performed with STATISTICA for Windows
version 9.1 (StatSoft, USA) and STATA (version 11, Statacorp, TX, USA). All
tests were two-sided, and a P-valueo0.05 was considered as statistically
signiﬁcant. Depending on the type of data, bivariate analyses between UIC
and potential inﬂuential factors were evaluated with Spearman correlation
coefﬁcient, Kendall Tau, or analysis of variance. Mann–Whitney’s U-test was
used to test differences in the distribution of continuous variables between
two independent groups.
For assessing the women’s iodine intake during pregnancy on a population
basis, we used the criteria developed by WHO,1 where a median
UICo150mg/l is considered to reﬂect insufﬁcient intake, 150–249mg/l—
adequate intake, 250–499mg/l—more than adequate, and Z500mg/l—
excessive intake.
To explore whether the micronutrient supplementation (Fe60Fol (usual
care), Fe30Fol, or MMS (including 150mg potassium iodine)) ingested
during pregnancy had any impact on the women’s UIC at GW30, we
estimated the mean UIC with linear regression and the 10th, 50th, and
90th percentiles of the UIC at GW30 with quantile regression. The exposure
variable of interest was micronutrient supplement (0¼ Fe60Fol (usual
care), 1¼ Fe30Fol, 2¼MMS). We considered the following potential
confounders: the women’s UIC at GW14 (baseline; categorized into
quartiles), age (numeric variable), BMI at GW8 (numeric variable), socio-
economic status (numeric, normalized variable), and food supplementation
ingested during pregnancy (usual start¼ 0, early start¼ 1).
RESULTS
The mean age of the 392 pregnant women followed from
enrollment at GW8 to delivery was 27 years (range 14–44 years;
Figure 1). The mean BMI of the women at GW8 was 20 kg/m2 and
about 30% of the women were classiﬁed as undernourished (BMI
o18.5 kg/m2). One-third of the women had no formal education,
and among those who had formal education the mean level of
education was 7 years (range 2–14 years). Seventy-two percent of
Randomly selected (n=500)
Live birth (n=392)
Loss to follow up (n=108)
Migrated (n=22)
Not located (n=28)
Refusal (n=22)
Abortion (n=9)
Miscarriage (n=6)
Hb<80 g/L (n=1)
Pills not distributed (n=2)
Twins (n=7)
Stillbirth (n=11)
Urine analyzed at GW8, 14, 19
and 30 (n=271)
GW8 urine/no urine (n=346/46)
GW14 urine/no urine (n=307/85)
GW19 urine/no urine (n=278/114)
GW30 urine/no urine (n=316/76)
Figure 1. Flow chart of study participation.
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the women were multiparous (range 1–7 children). None of the
women smoked tobacco during pregnancy, but 42% of the
women chewed betel/tobacco. The UIC at GW 8, 14, 19, and 30
was measured in 271 out of 392 women (Figure 1). The women
who had their UIC measured at four occasions did not differ from
the women who did not have their UIC measured at all four
occasions with regard to age, level of formal education, socio-
economic status, or BMI (GW8), but they were more likely to be
multiparous than primiparous (P¼ 0.013).
The women’s median UIC increased signiﬁcantly during
pregnancy (Po0.001), and the concentrations varied widely at
each gestational week (Table 1). The highest individual UIC of
11,694 mg/l was observed at GW19; however, this woman had a
much lower UIC, both before and after GW19 (GW14: 129 and
GW30: 156 mg/l, respectively). In early pregnancy (GW8 and 14),
30–31% of the women had a UIC o150 mg/l, and later in
pregnancy this percentage had decreased by 8–6% (Table 1). In
contrast, the percentage of women with a UIC Z500 mg/l
increased by 7% from GW8 to 30. Notably, we found that 15
women (6%) maintained a UIC o150 mg/l at all four sampling
occasions, and 26 women (10%) maintained a UIC Z500 mg/l.
We explored whether the women’s UIC were associated with
any demographic characteristics (Table 2) and found that the
women’s UIC from GW8 to 30 were positively associated with their
level of formal education (P for allo0.0073) and the family’s socio-
economic status (Po0.034; Table 2). Similarly, the women’s UIC
from GW14 to 30 were positively associated with the women’s
weight (Po0.046) and BMI (Po0.0062) in early pregnancy. We
observed no associations with age, parity, or betel/tobacco-
chewing habits during pregnancy. Additionally, we tested whether
the women’s UIC at GW8 was associated with the season of
sampling, and indeed, there was an overall difference (P¼ 0.037).
The concentration was lower during the monsoon season (median
175mg/l; n¼ 104) compared with the premonsoon (median:
265mg/l; n¼ 109; P¼ 0.059) and postmonsoon season (median:
279mg/l; n¼ 58; P¼ 0.16).
We performed multiple linear regression analyses (Model 1;
Table 3), to assesses whether the micronutrient supplementation
(Fe60Fol (usual care), Fe30Fol, or MMS (including 150mg
potassium iodine)) ingested during pregnancy had any impact
on the women’s UIC at GW30. We found that women who
ingested either MMS or Fe30Fol had similar mean UIC at GW30 as
those who ingested Fe60Fol (P¼ 0.77 and 0.60, respectively;
Table 3). Further adjustment for other covariates did not change
any estimates of the effect markedly (Model 2; Table 3). We also
performed quantile regression to explore if the micronutrient
supplementations had different impact on women who had either
low (10th percentile), medium (50th percentile), or high (90th
percentile) UIC at GW30 (Table 3). In women with low UIC, the
MMS supplementation increased their UIC by 49 mg/l compared
with women who only ingested Fe60Fol (P¼ 0.016). On the
contrary, in women with high UIC, the MMS supplementation
lowered their UIC by 247mg/l compared with women who only
ingested Fe60Fol (P¼ 0.030).
The women’s UIC at GW8 was positively associated with iodine
in drinking water (rs¼ 0.33; P¼ 0.004; n¼ 76). The median iodine
concentration in drinking water, collected from 100 tube-wells in
the study area, was 65 mg/l (10th–90th percentile 11–243 mg/l;
range 3.5–438 mg/l). Depth of the tube-well was available for 75
out of the 100 sampled tube-wells, and the average depth was
140m (range 40–330m). We found that the concentrations of
iodine in drinking water were positively associated with tube-well
depth (rs¼ 0.55; Po0.001), and after further examination, we
found that the higher iodine concentrations were more frequent
in tube-wells deeper than the average depth of Z140 (median
144mg/l; n¼ 37) compared with those with a depth of o140m
(median: 30 mg/l; n¼ 38; Po0.001; Figure 2).
DISCUSSION
The present study shows that the iodine intake of pregnant women
in Matlab, in rural Bangladesh, was adequate or even more than
Table 1. Urinary iodine concentrations at four different gestational
weeks of 271 Bangladeshi women.
Variables Gestational weeks (weeks; mean±SD)
8.3±2.2 14.4±1.7 19.8±1.9 30.7±1.9
Urinary iodine (mg/l)a
Median 241 268 296 300
25–75th
percentiles
118–484 129–540 152–569 148–592
10–90th
percentiles
62–836 74–826 89–948 83–1062
Total range 1.6–2459 13–2021 27–11,694 34–3323
n (%) o50mg/lb 16 (6%) 14 (5%) 5 (2%) 5 (2%)
n (%)o150 mg/lb 85 (31%) 80 (30%) 63 (23%) 68 (25%)
n (%)4500 mg/lb 59 (22%) 76 (28%) 81 (30%) 79 (29%)
aAdjusted for the mean specific gravity during pregnancy (1.010 g/ml).
bWorld Health Organization’s criteria for assessing iodine status on
population basis: children and non-pregnant women moderate iodine
deficiency o50 mg/l; for pregnant women insufficient intake o150 mg/l
and excessive intake Z500 mg/l.
Table 2. Spearman’s rank correlation coefficients (P-value) of associations between the women’s urinary iodine concentrations at different
gestational weeks and demographic characteristics.
Variables Urinary iodine (mg/l)a
GW8 GW14 GW19 GW30
Maternal age (years) 0.061 (0.32) 0.059 (0.33) 0.021 (0.73) 0.040 (0.52)
Maternal height (cm) 0.011 (0.85) 0.0050 (0.93) 0.015 (0.80)  0.093 (0.13)
Maternal weight (GW8; kg) 0.084 (0.17) 0.18 (0.0036) 0.15 (0.016) 0.12 (0.046)
BMI in early pregnancy (GW8; kg/m2) 0.099 (0.10) 0.21 (o0.001) 0.17 (0.0062) 0.19 (0.0015)
Parity (no. of children)  0.059 (0.33)  0.032 (0.60)  0.053 (0.39)  0.0058 (0.92)
Socio-economic status 0.19 (0.0014) 0.17 (0.0042) 0.17 (0.0062) 0.13 (0.034)
Formal education (years)b 0.14 (o0.001) 0.15 (o0.001) 0.11 (0.0073) 0.12 (0.0035)
Betel chewing (yes/no)c (0.59) (0.30) (0.61) (0.95)
aAdjusted to the average specific gravity during pregnancy (1.010 g/ml).
bAssessed by Kendal Tau.
cAssessed by Mann–Whitney U-test.
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adequate, according to the WHO criteria (median UIC between
150–249mg/l and 250–499mg/l, respectively).1 Notably, 6% of the
pregnant women had consistently insufﬁcient iodine intake
throughout the whole pregnancy period (UIC o150mg/l),
whereas 10% of the women had the opposite pattern with
excessive intake throughout pregnancy (UIC Z500mg/l). The
women’s UIC increased with increasing level of education, socio-
economic status, BMI, and iodine concentrations in drinking water,
and the concentrations varied by season of sampling. Compared
with the usual care (Fe60Fol), supplementation with a multiple
micronutrient capsule, including iodine, had a normalizing effect,
increasing the concentrations among the women with the lowest
UIC (10th percentile) at GW30 and decreasing the concentrations
among the women with the highest UIC (90th percentile) at GW30.
The latest national survey in Bangladesh, conducted between
September 2004 to March 2005, about 2 years after the present
urine samples were collected showed that pregnant women in
rural areas had much lower median UIC (142mg/l) than our
median UIC of 241mg/l at GW8.9 In the survey, the prevalence of
iodine deﬁciency among pregnant women in rural areas was
about 41% (o100mg/l) compared with 12–20% in the present
study, depending on gestational week. Even with a cutoff of
150mg/l,o31% of the women in Matlab had UIC below this level.
The survey provided no detailed information about excess iodine
intake (UIC Z500 mg/l); only that it was detected in 10% of all
women and that it was more pronounced in urban than in rural
areas. However, no distinction was made between non-pregnant
and pregnant women. Still, we can conclude that the prevalence
of excessive iodine intake was higher among pregnant women in
Matlab (about 22–30%). A more recent study conducted in a rural
area of northwestern Bangladesh showed that about 80% of the
pregnant women had UIC o150mg/l in both early and late
pregnancy.10 This indicates that there may be marked
geographical differences within Bangladesh concerning iodine
intake and that there is still a need to monitor iodine intake to
avoid both low as well as excessive intake.
Iodine deﬁciency, particularly during early pregnancy, has been
associated with impaired neurodevelopment.7,8,19 On the other
hand, excessive iodine intake during pregnancy has also been
associated with adverse effects in the mother and her offspring.20,21
In a Chinese study, the risk of subclinical hypothyroidism was
higher in pregnant women with more than adequate iodine intake
(UIC 4250mg/l vs o250mg/l; OR¼ 6.20; 95% CI: 6.6–264;
Po0.001).21 Subclinical hypothyroidism has been associated with
placental abruption and pre-term delivery.22 In a Japanese study, it
was shown that an estimated daily iodine intake of 820 to 3180mg
during pregnancy could result in hyperthyrotropinemia in the
infant, which in some cases appeared to be permanent.20 Whether
the consistently low or excessive iodine intake in some of the
pregnant women in Matlab is related to any adverse pregnancy
outcomes or adverse effects in their offspring remains to be
elucidated.
Table 3. Estimated effects of the different micronutrient supplementations (Fe60Fol, Fe30Fol, and MMS) ingested during pregnancy on the mean, as
well as the 10th, 50th, and 90th percentile of urinary iodine at GW30 using linear regression analyses and quantile regression analyses, respectively.
Variable Model 1 Model 2
B (95% CI) P-value B (95% CI) P-value
Linear regression, mean
Fe60Fol (reference group) — —
Fe30Fol  16 ( 120 to 89) 0.77  14 ( 119 to 89) 0.78
MMS  28 ( 133 to 76) 0.60  38 ( 143 to 68) 0.49
Quantile regression, 10th percentile
Fe60Fol (reference group) — —
Fe30Fol 6.6 ( 31 to 44) 0.73 0.77 ( 35 to 36) 0.97
MMS 43 (8.6 to 77) 0.014 49 (9.2 to 89) 0.016
Quantile regression, 50th percentile
Fe60Fol (reference group) — —
Fe30Fol  8.1 ( 67 to 51) 0.79  0.70 ( 71 to 70) 0.99
MMS 6.2 ( 63 to 76) 0.86 9.4 ( 66 to 84) 0.81
Quantile regression, 90th percentile
Fe60Fol (reference group) — —
Fe30Fol  203 ( 443 to 36) 0.096  132 ( 419 to 156) 0.37
MMS  310 ( 465 to  155) o0.001  247 ( 471 to  23) 0.030
Model 1 is adjusted for the women’s urinary iodine concentration at GW14 (baseline; categorized into quartiles). Model 2 is adjusted for the women’s urinary
iodine concentration at GW14 (baseline; categorized into quartiles), age, socio-economic status, BMI at GW8, and food supplementation ingested during
pregnancy (usual start¼ 0, early start¼ 1).
Figure 2. Concentrations of iodine in drinking water by depth of the
tube-well (o140m and Z140m).
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Because the glomerular ﬁltration rate increases during preg-
nancy, we adjusted the UIC for the average SG during pregnancy,
to minimize the variation caused by dilution of urine as well as
increased urine volume. Previous studies have mainly related the
UIC to urinary creatinine.23–25 This was not possible in the present
study, as the urinary creatinine excretion is very low in the present
population, due to undernourishment and low protein intake.17
Thus correcting for urinary creatinine would have overestimated
the iodine intake. We found that the SG-adjusted median UIC
increased as pregnancy progressed. In contrast, the opposite
pattern was observed exploring the crude median UIC (GW8:
248mg/l; GW14: 180 mg/l; GW19: 196mg/l; and GW30: 204 mg/l). Our
results are in accordance with observations in studies conducted
in Belgium and Japan where the median UIC:creatinine ratio was
lower than the crude median UIC during the ﬁrst trimester,
whereas the opposite pattern was observed in the third
trimester.23,25 These ﬁndings conﬁrm that the increased glome-
rular ﬁltration during pregnancy has a large impact on the UIC.
However, to note, a Swiss study found that both the UIC:creatinine
ratio and the crude UIC decreased from the ﬁrst to the third
trimester.24 Therefore, it can be speculated that these dis-
similarities in the pattern of UI excretion during pregnancy are
not only dependent on the glomerular ﬁltration rate but also on
the initial iodine status of the women (deﬁcient/moderate/
sufﬁcient), ethnic dietary habits, and supplement use, as well as
differences in study design and sample size.
Iodized salt has been the main instrument in the combat against
iodine deﬁciency in Bangladesh since 1989.9 Unfortunately, we did
not have any information concerning the iodine content in the salt
utilized in each household. However, as the women’s UIC increased
with increasing level of education, socio-economic status, and BMI,
known determinants for the usage of iodized salt in other regions of
Bangladesh,26 iodized salt is most likely the main source of iodine
intake. These ﬁndings also show that women who are poor and
undernourished, and thus already have an increased risk of adverse
pregnancy outcomes and poor growth and development of their
offspring after delivery,27,28 are indeed also those with the highest
risk of insufﬁcient iodine intake.
Surprisingly, the supplementation with 150mg iodine among
approximately 30% of the women appeared to have marginal
impact on the women’s UIC when assessing the mean concentra-
tion at GW30. However, when assessing women with either low
(10th percentile) or high (90th percentile) UIC, we found that the
supplementation had different effects; positive in women with low
concentrations and inverse in women with high concentrations
when comparing with those who received the usual care
(Fe60Fol). The reasons for why the supplementation did not
affect some women’s UIC or why it even had a negative impact on
the UIC in women with high iodine intake are unknown.
Supplementation with a daily dose of 150 mg iodine during
pregnancy is in accordance with the recommendations by the
American Thyroid Association,29 but it is lower than the total
recommended daily intake of 250mg by WHO.1 Moreover, several
other trials have shown that iodine supplementation with doses
varying from 50mg/day to 230 mg/day signiﬁcantly increased the
UIC, despite the fact that not all individuals were considered to be
iodine deﬁcient.30,31 Thus, more studies are needed to conﬁrm
and to further explore the present ﬁndings.
Interestingly, we found that drinking water, especially that from
deeper tube-wells (Z140m), also contained rather high iodine
concentrations (10–90th percentile 42–332mg/l). Assuming a daily
intake of 3–4 l of water, a women consuming drinking water with the
concentrations of the 90th percentile would ingest about 996–
1328mg of iodine via drinking water only. Indeed, the increasing UIC
with increasing iodine concentrations in drinking water in the
present study conﬁrm that water may actually contribute to the daily
iodine intake. In accordance, a Chinese study also found a positive
association between concentrations of iodine in urine and drinking
water.32 They also observed that the iodine concentrations in
drinking water correlated with indicators of thyroid size, however, it
should be noted that the water concentrations were higher (median
552mg/l) than in the present study (median 144mg/l).
The main strengths of this study are that the UIC was measured
at four different occasions throughout pregnancy and that all
measurements of iodine were performed with ICP-MS a highly
accurate, precise, high-throughput method. The main limitations
were the lack of information concerning iodine concentrations in
edible salt utilized by each household and that we had no markers
of the women’s thyroid function. It would also have been
informative to have a control group of non-pregnant women
residing in the same area for comparison.
In conclusion, pregnant women in Matlab, in rural Bangladesh,
have generally, adequate or even more than adequate iodine
intake during pregnancy. However, it should be noted that both
low and excessive iodine intake also occurred in some women
throughout the whole pregnancy period. Supplementation with a
multiple micronutrient capsule, including iodine, appeared to
increase the UIC of women with the lowest iodine intake.
Demographic factors that have previously been associated with
the use of iodine salt, as well as season of sampling and iodine
concentrations in drinking water, inﬂuenced the women’s UIC.
Further studies are needed to clarify the potential impact the
women’s consistently low or excessive iodine intake may have had
on the health of their developing offspring.
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